X-37798966-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 3P and 14B. PM1PP3BP4_StrongBP6_ModerateBS1BS2
The NM_000397.4(CYBB):c.686G>A(p.Arg229His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000246 in 1,205,587 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 82 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0010 ( 0 hom., 34 hem., cov: 23)
Exomes 𝑓: 0.00017 ( 0 hom. 48 hem. )
Consequence
CYBB
NM_000397.4 missense
NM_000397.4 missense
Scores
9
6
2
Clinical Significance
Conservation
PhyloP100: 9.56
Genes affected
CYBB (HGNC:2578): (cytochrome b-245 beta chain) Cytochrome b (-245) is composed of cytochrome b alpha (CYBA) and beta (CYBB) chain. It has been proposed as a primary component of the microbicidal oxidase system of phagocytes. CYBB deficiency is one of five described biochemical defects associated with chronic granulomatous disease (CGD). In this disorder, there is decreased activity of phagocyte NADPH oxidase; neutrophils are able to phagocytize bacteria but cannot kill them in the phagocytic vacuoles. The cause of the killing defect is an inability to increase the cell's respiration and consequent failure to deliver activated oxygen into the phagocytic vacuole. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM1
In a topological_domain Extracellular (size 39) in uniprot entity CY24B_HUMAN there are 6 pathogenic changes around while only 0 benign (100%) in NM_000397.4
PP3
Multiple lines of computational evidence support a deleterious effect 9: AlphaMissense, BayesDel_addAF, BayesDel_noAF, Cadd, Dann, M_CAP, MutationAssessor, phyloP100way_vertebrate, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.032025635).
BP6
Variant X-37798966-G-A is Benign according to our data. Variant chrX-37798966-G-A is described in ClinVar as [Benign]. Clinvar id is 533561.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-37798966-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00103 (115/111852) while in subpopulation AFR AF= 0.00353 (109/30839). AF 95% confidence interval is 0.003. There are 0 homozygotes in gnomad4. There are 34 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 34 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYBB | NM_000397.4 | c.686G>A | p.Arg229His | missense_variant | 7/13 | ENST00000378588.5 | NP_000388.2 | |
CYBB | XM_047441855.1 | c.380G>A | p.Arg127His | missense_variant | 6/12 | XP_047297811.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYBB | ENST00000378588.5 | c.686G>A | p.Arg229His | missense_variant | 7/13 | 1 | NM_000397.4 | ENSP00000367851.4 | ||
ENSG00000250349 | ENST00000465127.1 | c.171+372966G>A | intron_variant | 5 | ENSP00000417050.1 |
Frequencies
GnomAD3 genomes AF: 0.00103 AC: 115AN: 111801Hom.: 0 Cov.: 23 AF XY: 0.000998 AC XY: 34AN XY: 34083
GnomAD3 genomes
AF:
AC:
115
AN:
111801
Hom.:
Cov.:
23
AF XY:
AC XY:
34
AN XY:
34083
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000346 AC: 61AN: 176325Hom.: 0 AF XY: 0.000243 AC XY: 15AN XY: 61745
GnomAD3 exomes
AF:
AC:
61
AN:
176325
Hom.:
AF XY:
AC XY:
15
AN XY:
61745
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000166 AC: 182AN: 1093735Hom.: 0 Cov.: 29 AF XY: 0.000133 AC XY: 48AN XY: 360155
GnomAD4 exome
AF:
AC:
182
AN:
1093735
Hom.:
Cov.:
29
AF XY:
AC XY:
48
AN XY:
360155
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00103 AC: 115AN: 111852Hom.: 0 Cov.: 23 AF XY: 0.000996 AC XY: 34AN XY: 34144
GnomAD4 genome
AF:
AC:
115
AN:
111852
Hom.:
Cov.:
23
AF XY:
AC XY:
34
AN XY:
34144
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
13
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
62
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Granulomatous disease, chronic, X-linked Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Chronic granulomatous disease Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 05, 2019 | - - |
CYBB-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 16, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at